Early Access — free while we kick the tires
EdgarHawk

RICHMOND DONALD P. II

CTO

Officer
2 filings analyzed · 1 company · Latest 2026-04-15

Never miss a filing from RICHMOND DONALD P. II

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
AEHR TEST SYSTEMS AEHR 0 2 Net selling

Activity

April 2026
2026-04-15 AEHR TEST SYSTEMS AEHR
high
Sell
17,011 shares
$1,244,804
Significance 7/10

CTO Richmond sells 17,011 AEHR shares at $73.18; stock surged +95.4% in 30d, down to $73.22 now; company unprofitable with -11.0% revenue decline

Richmond, AEHR's CTO, sold 17,011 shares at $73.18 on 2026-04-14, reducing his holdings by 8.6%. The sale occurred near the 52-week high of $74.38 and follows an extraordinary 95.4% rally over the prior 30 days and 176.0% surge over 90 days. At AEHR specifically, Richmond's prior two measurable sales (2023-08-09 and 2023-08-10) both proved well-timed at the 90-day mark, with subsequent declines of -50.9% and -53.4% respectively. The sale timing aligns with this pattern of downside-protective exits. However, the underlying business context is deteriorating: the company posted $-3.2M net loss in the latest quarter, -11.0% annual revenue contraction, and remains unprofitable on a full-year basis, with a market cap of $2.3B against $10.3M quarterly revenue. The sharp stock rally into this sale, combined with persistent negative fundamentals, creates a notable divergence between price momentum and operating reality.

2026-04-10 AEHR TEST SYSTEMS AEHR
high
Sell
15,751 shares
$1,081,856
Significance 7/10

CTO Donald Richmond II sold 15,751 shares of AEHR at $68.68 for $1.1M; stock at 52-week high, 90d +167.6%

Richmond sold 15,751 shares (15.8K shares) representing 7.3% of his pre-transaction holdings of 214,996 shares (215.0K shares). The sale occurred at $68.68, which matches the 52-week high of $70.43, occurring immediately after a 90-day surge of +167.6% and 30-day gain of +65.9%. Across his cross-ticker track record, Richmond's 2 prior sells showed a 90d well-timed rate of 100.00%, and at AEHR specifically, both prior 2023 sells exhibited negative 90-day returns (−53.4% and −50.9%), indicating a pattern of selling ahead of downturns. However, the company's fundamentals show revenue of $10,313,000.00 ($10.3M) in the latest quarter paired with net income of $-3,203,000.00 ($-3.2M) and annual revenue growth of −11.0%, reflecting ongoing unprofitability and contracting sales. The sale follows a dramatic near-term rally into historical highs, which may explain the execution despite the company's deteriorating operational position.

Related insiders